W ang Qiangxiang is the chairman and co-founder of CoCreation Grass (CCGrass), the world's largest manufacturer of artificial turf. He founded the company in 2004 in Nanjing with his brother, Wang Qiangzhong. Identifying a niche global market, Wang built CCGrass into a dominant supplier, with its products used in over 120 countries for both sports fields and landscape gardening.
Under his leadership, the company achieved the prestigious status of a FIFA Preferred Provider and supplies turf to major sporting bodies like World Rugby and the FIH (International Hockey Federation). CCGrass operates massive manufacturing facilities in China and Vietnam. Wang's focus on R&D and global quality standards enabled the company to list on the Shanghai Stock Exchange in 2018, securing his position as a leader in the synthetic surfacing industry.
Advertisement
Wang Qiangxiang is a Chinese businessman, the Chairman of CoCreation Grass, or CCGrass, which describes itself as the largest synthetic turf supplier in the world.
CCGrass was founded by Wang Qiangxiang and his brother Wang Qiangzhong in 2004 in Nanjing. The company's turf products are used for both athletic and landscape purposes.
Wang Qiangxiang's career is defined by his success in scaling industrial materials manufacturing for a global niche market. His structural achievement is tied to building CCGrass into the largest supplier of synthetic turf, a product used in sports and landscaping worldwide.
CCGrass supplies major international sports organizations, including FIFA, FIH, World Rugby, GAA and ITF, demonstrating the high quality and scale of its products.
Advertisement
Founded CoCreation Grass (CCGrass) with his brother Wang Qiangzhong in Nanjing.
CCGrass supplies FIFA, World Rugby, and other major sports organizations.
Continues as Chairman.
Wang Qiangxiang's wealth is concentrated in his family's controlling stake and continued leadership of the industrial manufacturing giant, CoCreation Grass.
Advertisement
Advertisement
No publicly available quotes.
Advertisement
+1.39% | +$84.86M
-0.56% | -$217.58M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content